Immuno-Biological Laboratories Co., Ltd. (4570.T)
JPY 458.0
(-2.35%)
JPY 458.0
(-2.35%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 20.05 JPY | 164.19% |
| 2022 | -31.11 JPY | -11.99% |
| 2021 | -27.78 JPY | 18.84% |
| 2020 | -34.23 JPY | 54.95% |
| 2019 | -75.99 JPY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 5.48 JPY | -69.08% |
| 2023 Q3 | -0.67 JPY | -141.61% |
| 2023 Q1 | 1.19 JPY | 105.2% |
| 2023 Q4 | 17.82 JPY | 2759.7% |
| 2023 FY | - JPY | 164.19% |
| 2023 Q2 | 1.61 JPY | 35.29% |
| 2022 Q3 | 6.41 JPY | 177.32% |
| 2022 FY | - JPY | -11.99% |
| 2022 Q4 | -22.90 JPY | -457.25% |
| 2022 Q2 | -8.29 JPY | 0.0% |
| 2021 FY | - JPY | 18.84% |
| 2020 FY | - JPY | 54.95% |
| 2019 FY | - JPY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 92.20 JPY | 78.254% |
| PRISM BioLab Co.,LTD | -14.90 JPY | 234.564% |
| GNI Group Ltd. | 169.50 JPY | 88.171% |
| Linical Co., Ltd. | 14.98 JPY | -33.845% |
| Trans Genic Inc. | 0.24 JPY | -8254.167% |
| MEDINET Co., Ltd. | -6.65 JPY | 401.504% |
| Soiken Holdings Inc. | -25.32 JPY | 179.186% |
| Cytori Cell Research Institute, Inc. | 15.47 JPY | -29.606% |
| AnGes, Inc. | -39.29 JPY | 151.031% |
| OncoTherapy Science, Inc. | -6.05 JPY | 431.405% |
| Nxera Pharma Co., Ltd. | -87.17 JPY | 123.001% |
| NanoCarrier Co., Ltd. | -11.10 JPY | 280.631% |
| Carna Biosciences, Inc. | -68.62 JPY | 129.219% |
| CanBas Co., Ltd. | -67.87 JPY | 129.542% |
| D. Western Therapeutics Institute, Inc. | -25.56 JPY | 178.443% |
| RaQualia Pharma Inc. | -14.98 JPY | 233.845% |
| Chiome Bioscience Inc. | -24.62 JPY | 181.438% |
| Kidswell Bio Corporation | -40.23 JPY | 149.838% |
| PeptiDream Inc. | 23.41 JPY | 14.353% |
| Oncolys BioPharma Inc. | -108.92 JPY | 118.408% |
| Ribomic Inc. | -28.70 JPY | 169.861% |
| SanBio Company Limited | -40.48 JPY | 149.531% |
| Healios K.K. | -56.22 JPY | 135.663% |
| BrightPath Biotherapeutics Co., Ltd. | -18.21 JPY | 210.104% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -26.79 JPY | 174.841% |
| Delta-Fly Pharma, Inc. | -198.72 JPY | 110.09% |
| StemRIM | -32.98 JPY | 160.794% |
| CellSource Co., Ltd. | 48.88 JPY | 58.981% |
| FunPep Company Limited | -39.63 JPY | 150.593% |
| Kringle Pharma, Inc. | -158.46 JPY | 112.653% |
| Stella Pharma Corporation | -24.66 JPY | 181.306% |
| TMS Co., Ltd. | -26.02 JPY | 177.056% |
| Noile-Immune Biotech Inc. | -27.25 JPY | 173.578% |
| Cuorips Inc. | -85.87 JPY | 123.349% |
| K Pharma,Inc. | 22.43 JPY | 10.611% |
| Takara Bio Inc. | 12.29 JPY | -63.141% |
| ReproCELL Incorporated | -0.37 JPY | 5518.919% |
| PhoenixBio Co., Ltd. | 6.88 JPY | -191.424% |
| StemCell Institute Inc. | 30.25 JPY | 33.719% |
| Japan Tissue Engineering Co., Ltd. | 3.53 JPY | -467.989% |
| CellSeed Inc. | -29.43 JPY | 168.128% |